Inovio stock plunges after U.S. government pulls funding for late-stage testing of Covid-19 vaccine candidate
April 23, 2021 at 10:58 AM EDT
The Plymouth Meeting biotechnology company has been working on its potential Covid-19 vaccine since early 2020.